Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Array Biopharma Inc (ARRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,210,694
  • Shares Outstanding, K 210,640
  • Annual Sales, $ 150,850 K
  • Annual Income, $ -116,820 K
  • 36-Month Beta 1.79
  • Price/Sales 26.53
  • Price/Cash Flow N/A
  • Price/Book 14.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.38 +27.11%
on 05/25/18
20.21 -3.27%
on 06/21/18
+4.23 (+27.61%)
since 05/21/18
3-Month
12.80 +52.73%
on 05/09/18
20.21 -3.27%
on 06/21/18
+2.75 (+16.37%)
since 03/21/18
52-Week
7.15 +173.43%
on 08/03/17
20.21 -3.27%
on 06/21/18
+10.56 (+117.46%)
since 06/21/17

Most Recent Stories

More News
Array BioPharma (ARRY) Looks Good: Stock Adds 5.2% in Session

Array BioPharma (ARRY) shares rose more than 5% in the last trading session, amid huge volumes.

GHDX : 51.38 (-0.96%)
ARRY : 19.55 (-2.20%)
Biotech Resurgent Growth Championed by Cancer Research and Clinical Trial Advancements

MarketNewsUpdates.com News Commentary

EOLS : 31.94 (+0.54%)
WEED.TO : 47.76 (+5.29%)
SRPT : 149.65 (-2.63%)
ARRY : 19.55 (-2.20%)
MBRX : 1.87 (-13.82%)
NEPT : 3.75 (-15.73%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Array Biopharma (ARRY , ONCE , REGN , FGEN , BCRX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ONCE : 88.49 (-2.32%)
ARRY : 19.55 (-2.20%)
REGN : 329.04 (-2.34%)
Look for Shares of Array Biopharma to Potentially Rebound after Yesterday's 2.73% Sell Off

Array Biopharma (NASDAQ:ARRY) traded in a range yesterday that spanned from a low of $17.44 to a high of $18.15. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $17.72...

ARRY : 19.55 (-2.20%)
Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer

Array BioPharma Inc. (Nasdaq: ARRY) announced that it will present updated safety and efficacy results, including overall survival (OS) data, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating...

ARRY : 19.55 (-2.20%)
Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma

Array BioPharma Inc. (NASDAQ: ARRY) today announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma. The results showed median overall survival (mOS) was 33.6 months for...

ARRY : 19.55 (-2.20%)
Key FDA Events in June Investors Need to Watch Out For

Investors in the healthcare industry are likely to keep a watch on upcoming PDUFA dates for key drugs in Jun 2018.

ARRY : 19.55 (-2.20%)
AKAO : 12.45 (-4.38%)
MRK : 61.18 (-0.16%)
GWPH : 151.01 (-1.00%)
ALKS : 43.65 (-15.01%)
VRX : 24.72 (+0.32%)
Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference in New York. The public is welcome to participate...

ARRY : 19.55 (-2.20%)
Array BioPharma To Present at the Jefferies 2018 Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference in New York. The public is welcome to participate...

ARRY : 19.55 (-2.20%)
Array BioPharma Announces Oral Presentation from the Pivotal Phase 3 COLUMBUS trial of the Combination of Encorafenib and Binimetinib in Patients with BRAF-mutant Melanoma at 2018 ASCO Annual Meeting

Array BioPharma Inc. (Nasdaq: ARRY) announced that it will present data from the Phase 3 COLUMBUS trial of encorafenib and binimetinib in advanced BRAF-mutant melanoma in an oral presentation on June 4,...

ARRY : 19.55 (-2.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ARRY with:

Business Summary

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory...

See More

Key Turning Points

2nd Resistance Point 20.64
1st Resistance Point 20.10
Last Price 19.55
1st Support Level 19.12
2nd Support Level 18.68

See More

52-Week High 20.21
Last Price 19.55
Fibonacci 61.8% 15.22
Fibonacci 50% 13.68
Fibonacci 38.2% 12.14
52-Week Low 7.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar